133 related articles for article (PubMed ID: 31648010)
1. Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.
Vignini A; Alia S; Pugnaloni S; Giulietti A; Bacchetti T; Mazzanti L; Luzzi S; Fiorini R
Exp Gerontol; 2019 Dec; 128():110754. PubMed ID: 31648010
[TBL] [Abstract][Full Text] [Related]
2. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
3. Effects of DHA-phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment.
Cazzola R; Rondanelli M; Faliva M; Cestaro B
Exp Gerontol; 2012 Dec; 47(12):974-8. PubMed ID: 23000875
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
[TBL] [Abstract][Full Text] [Related]
5. Platelet and erythrocyte membrane changes in Alzheimer's disease.
Hajimohammadreza I; Brammer MJ; Eagger S; Burns A; Levy R
Biochim Biophys Acta; 1990 Jun; 1025(2):208-14. PubMed ID: 2142000
[TBL] [Abstract][Full Text] [Related]
6. Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China.
Yuan L; Liu J; Ma W; Dong L; Wang W; Che R; Xiao R
Nutrition; 2016 Feb; 32(2):193-8. PubMed ID: 26690564
[TBL] [Abstract][Full Text] [Related]
7. Relation of plasma selenium and lipid peroxidation end products in patients with Alzheimer's disease.
Chmatalova Z; Vyhnalek M; Laczo J; Hort J; Pospisilova R; Pechova M; Skoumalova A
Physiol Res; 2017 Dec; 66(6):1049-1056. PubMed ID: 28937243
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
[TBL] [Abstract][Full Text] [Related]
9. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
10. Detection of membrane fluidity in submitochondrial particles of platelets and erythrocyte membranes from Mexican patients with Alzheimer disease by intramolecular excimer formation of 1,3 dipyrenylpropane.
Ortiz GG; Pacheco-Moisés F; El Hafidi M; Jiménez-Delgado A; Macías-Islas MA; Rosales Corral SA; de la Rosa AC; Sánchez-González VJ; Arias-Merino ED; Velázquez-Brizuela IE
Dis Markers; 2008; 24(3):151-6. PubMed ID: 18334736
[TBL] [Abstract][Full Text] [Related]
11. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
12. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes.
van Rensburg SJ; Carstens ME; Potocnik FC; Aucamp AK; Taljaard JJ; Koch KR
Neurochem Res; 1992 Aug; 17(8):825-9. PubMed ID: 1641066
[TBL] [Abstract][Full Text] [Related]
13. Plasma Homocysteine and Serum Folate and Vitamin B
Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
[TBL] [Abstract][Full Text] [Related]
14. Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimer's disease.
Silva DF; Santana I; Esteves AR; Baldeiras I; Arduino DM; Oliveira CR; Cardoso SM
Curr Alzheimer Res; 2013 Feb; 10(2):180-90. PubMed ID: 22746213
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
[TBL] [Abstract][Full Text] [Related]
17. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease.
Waragai M; Yoshida M; Mizoi M; Saiki R; Kashiwagi K; Takagi K; Arai H; Tashiro J; Hashimoto M; Iwai N; Uemura K; Igarashi K
J Alzheimers Dis; 2012; 32(1):33-41. PubMed ID: 22751175
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
Schrag M; Mueller C; Zabel M; Crofton A; Kirsch WM; Ghribi O; Squitti R; Perry G
Neurobiol Dis; 2013 Nov; 59():100-10. PubMed ID: 23867235
[TBL] [Abstract][Full Text] [Related]
19. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
[TBL] [Abstract][Full Text] [Related]
20. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
